30 Day Trial

RTI Surgical Reduces Guidance Due to Softer than Expected coflex Sales


RTI Surgical reports 3Q19 orthopedic revenue of USD $65.7MM, +10.7% vs. 3Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.